Filter
420
Text search:
comorbidity
Featured
Recommendations
32
New Publications
56
Language
Document type
No document type
250
Studies & Reports
76
Guidelines
54
Manuals
15
Fact sheets
11
Strategic & Response Plan
8
Training Material
5
Situation Updates
1
Countries / Regions
Global
22
India
18
Western and Central Europe
14
Latin America and the Carribbean
11
South Africa
9
Africa
8
Brazil
7
Russia
7
Ukraine
6
Eastern Europe
6
Germany
4
Sierra Leone
3
Indonesia
3
Mozambique
3
Namibia
3
Peru
3
Colombia
3
Asia
3
Nigeria
2
USA
2
Ethiopia
2
Uganda
2
Nepal
2
Tanzania
2
Rwanda
2
Myanmar / Burma
2
Middle East and North Africa
2
South–East Asia Region
2
United Kingdom
2
Senegal
1
Congo, Democratic Republic of
1
Cameroon
1
Ghana
1
Togo
1
Zimbabwe
1
Philippines
1
Zambia
1
Egypt
1
Syria
1
Chad
1
Kenya
1
Thailand
1
China
1
Ireland
1
Singapore
1
Malawi
1
Benin
1
Central African Republic
1
Argentina
1
Eswatini/ Swaziland
1
Ecuador
1
Botswana
1
Bolivia
1
Angola
1
Chile
1
Western Pacific Region
1
Palestine
1
Canada
1
Tajikistan
1
Mauritius
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
25
Public Health
22
Women & Child Health
2
Key Resources
1
Toolboxes
Mental Health
206
COVID-19
43
TB
31
HIV
23
NCDs
22
Disability
11
Caregiver
6
Cholera
4
Refugee
4
NTDs
4
AMR
3
Ebola & Marburg
2
Polio
2
Pharmacy
2
Conflict
1
Planetary Health
1
Malaria
1
Anxiety Disorders
Chapter F.4
Key populations brief
Accessed November 2017
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s
...
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain areas associated with mood regulation. Finally, I d
...
Depression Research and Treatment
Volume 2012, Article ID 962860, 8 pages
doi:10.1155/2012/962860
Dialogues Clin Neurosci. 2017 Jun; 19(2): 93–107.
An estimated 1.3 billion people – or 16% of global population worldwide – experience a significant disability today. Persons with disabilities have the right to the highest attainable standard of health as those without disabilities. However, the WHO Global report on health equity for persons w
...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base
...
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co
...
Fortbildung | VNR 2760602016064370005 | Hessisches Ärzteblatt 5/2016 | Die weltweit zu beobachtende Flucht von Menschen vor Krieg, Gewalt, Verfolgung und Hunger stellt auch für die medizinischen Versorgungssysteme in Deutschland eine große Herausforderung dar. Neben der Versorgung somatischer Kra
...
Trastornos de ansiedad
Capítulo F.2
Versión en español:
Editor: Cesar Soutullo
Traductores: Andrea Candelas-Muñoz, Cecilia Hernández-González, Ana Mena
In this entry we are looking at smoking, alcohol consumption and the use of illicit drugs. We are studying who is using these substances, how their use has changed over time, and we are presenting the estimates of their impact on health. Collectively, smoking, alcohol and illicit drug use kills 11.8
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec
...
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h
...
People with asthma (PWA) generally are considered at higher risk from respiratory infections, as is seen annually with influenza. At the outset of the COVID-19 pandemic, PWA were widely assumed to be at increased risk from COVID-19. However, as data emerged throughout 2020, the association between a
...
Anxiety disorders
Chapter F.2
